| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |